Severe asthma affects roughly 2 million people in the United States. It is hard to control — even with inhaled steroid medicines and additional therapies. More than 80% of cases are linked to type 2 ...
Nearly 26 million people in the United States have asthma. That’s about 1 in 13 people. Rates are highest in the Black, Hispanic, and American Indian/Alaska Native populations. Asthma affects 4.8 ...
Asthma is one of the most common lung diseases in the world, affecting some 262 million people worldwide and causing more than 450,000 deaths annually, per the World Health Organization. While ...
GlobalData on MSN
Fasenra shows benefit in acute asthma and COPD in Phase II trial
A Phase II investigator-led trial investigating AstraZeneca’s Fasenra (benralizumab) treating eosinophilic exacerbations of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Fewer adolescents in the GLP-1 receptor agonist group vs ...
As winter rolls on in Australia, respiratory viruses are everywhere. One of the main culprits is respiratory syncytial virus, or RSV, which has caused more than 145,000 infections around the country ...
Childhood asthma is likely related to a combination of environmental and biological factors. Exercise, smoke, infections, and allergies are some things that can trigger worsening asthma symptoms.
GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...
Connect Biopharma Holdings Limited has announced the initiation of its Phase 2 Seabreeze STAT Asthma study, which aims to evaluate the safety and efficacy of rademikibart in treating acute ...
Please provide your email address to receive an email when new articles are posted on . 1.9% of the U.S. cohort died during the study period. 14% of reported deaths had a contributory COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results